Aevi genomic medicine, inc. (GNMX)
CashFlow / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-30,775

-34,714

-41,904

-37,992

-18,433

-17,129

-15,071

-8,096

-4,147

Adjustments to reconcile loss to net cash used in operating activities:
Depreciation

65

112

268

240

225

177

145

98

120

Loss from disposal of property and equipment

0

-32

0

-18

0

-1

0

0

-

Stock-based compensation

3,090

3,368

6,788

9,188

6,202

4,784

3,007

-

-

Stock-based consideration related to acquisition

-

-

0

3,200

0

0

-

-

-

Changes in fair value of warrants classified as a liability

-

-

0

1,370

-585

-720

2,336

-

-

Accrued severance pay, net

-

-

0

269

74

416

-

-

-

Accrued severance pay, net

-

-

-

-

-

-

-

-

39

Exchange differences on a restricted lease deposit and on long term loan

-

-

-

-

-

-

5

-4

-1

Loss from disposal of property and equipment

-

-

-

-

-

-

-

-

-1

Issuance of shares as consideration for providing security for letter of credit

-

-

-

-

-

-

-

-

0

Stock-based compensation related to options, warrants, common shares and restricted shares granted to employees, directors and consultants

-

-

-

-

-

-

-

395

1,834

Interest and amortization of beneficial conversion feature of convertible note

-

-

-

-

-

-

-

0

0

Change in fair value of convertible debentures and warrants

-

-

-

-

-

-

-

1,936

-633

Accrued severance pay, net

-

-

-

-

-

-

140

300

-

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

-723

558

-412

432

113

-

-

-

-

Other accounts payable and accrued expenses

-

-

-

-

-

-

-

-79

-787

Restricted lease deposit

-

-

-

-

-

-3

-5

10

-

Accounts receivable and prepaid expenses

-

-

-

-

-

-360

-543

-533

-

Exchange differences on a long-term loan

-

-

-

-

-

-

-

-

0

Decrease (increase) in accounts receivable and prepaid expenses and deferred issuance expenses

-

-

-

-

-

-

-

-

1,644

Exchange differences on a restricted lease deposit

-

-

-

-

-

-

-

-

-1

Exchange differences on a long term loan

-

-

-

-

-

-

-

-

0

Trade payables

639

806

-1,185

246

14

185

-26

764

-204

Other accounts payable and accrued expenses

-434

-2,249

2,860

24

610

29

317

-

-

Lease deposits

0

0

-

-

-

-

-

-

-

Restricted lease deposits

-

-

-12

-60

41

-

-

-

-

Other long term assets

-43

43

0

0

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-12,195

-12,732

-8,619

-8,027

-

Net cash used in operating activities

-26,649

-33,246

-32,749

-24,347

-

-

-

-

-4,154

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

0

4

221

187

364

186

63

289

61

Proceeds from disposal of property and equipment

0

152

0

0

1

3

0

0

0

Net cash used in investing activities

-

-

-

-

-363

-183

-63

-289

-

Increase in restricted lease deposit

-

-

-

-

-

-

-

-

8

Net cash provided by (used in) investing activities

0

148

-221

-187

-

-

-

-

-69

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of shares, net

4,962

26,970

19,563

42,882

22,212

28,861

8,407

10,389

-

Proceeds from issuance of shares and warrants, net

-

-

-

-

-

-

-

-

2,077

Proceeds from exercise of options and warrants

34

19

181

1,428

1,244

13

1,711

63

534

Repayment of a long-term loan

-

-

-

-

-

-

-

0

0

Proceeds from long-term loan

-

-

-

-

-

-

-

0

0

Issuance of a convertible debenture and warrants

-

-

-

-

-

-

-

0

4,001

Net cash provided by financing activities

-

-

-

-

23,456

28,874

10,118

10,452

-

Net cash provided by financing activities

4,996

26,989

19,744

44,310

-

-

-

-

6,612

Decrease in cash and cash equivalents

-21,653

-6,109

-13,226

19,776

10,898

15,959

1,436

2,136

2,389

Interest

-

-

-

-

-

-

-

49

117

Cash paid during the period for taxes

0

0

26

19

12

17

50

1

14

Classification of liability in respect of warrants into equity due to the exercise of warrants

-

-

0

1,982

14

0

-

-

-

Issuance expenses paid with shares

-

-

-

-

-

-

-

0

0

Issuance of Common stock upon conversion of a convertible debentures

-

-

-

-

-

-

-

5,585

0

Issuance of Common stock and warrants to consultants

-

-

-

-

-

-

-

-

451

Classification of liability in respect of warrants into equity due to the exercise of warrants

-

-

-

-

-

-

883

1,131

0